Photo of Alan E Gross

Alan E Gross


Clinical Associate Professor, Pharmacy Practice

Contact

Building & Room:

CSB Rm 336

Address:

833 S. Wood St., 164 PHARM, Chicago, IL, 60612

Office Phone:

(312) 996-7985

Email:

aegross@uic.edu

About

Research Interests: Dr. Gross's research interests include the epidemiology and treatment of multidrug-resistant organisms, and evaluating outcomes related to antimicrobial stewardship interventions.

Selected Publications

  • Gross AE, MacDougall C. “Authors’ response to Barlow et al.”. Journal of the American College of Clinical Pharmacy. . doi:10.1002/jac5.1251.

  • Gross AE, MacDougall C. “Roles of the clinical pharmacist during the COVID-19 pandemic”. Journal of the American College of Clinical Pharmacy. 2020;3(3):564-566. doi:10.1002/jac5.1231.

  • Craddock K, Molino S, Stranges PM, Suda K, Bleasdale SC, Radosta J, Kannampallil T, Shapiro NL, Gross AE. “The impact of educational interventions on antibiotic prescribing for acute upper respiratory tract infections in the ambulatory care setting: A quasi-experimental study”. Journal of the American College of Clinical Pharmacy. 2020;3(3):609-614. doi:10.1002/jac5.1205.

  • Gross AE, Hanna D, Rowan SA, Bleasdale SC, Suda K. Successful Implementation of an Antibiotic Stewardship Program in an Academic Dental Practice.. Open forum infectious diseases. 2019;6(3):ofz067. doi:10.1093/ofid/ofz067.

  • Sarna KV, Gross AE. Vancomycin Versus Metronidazole for Nonsevere Clostridioides difficile Infection: Are the Data Adequate to Change Practice?. The Annals of pharmacotherapy. 2019;:1060028019829764. doi:10.1177/1060028019829764.

  • Gross AE, Suda K. Sample Business Plan – Antimicrobial Stewardship Program in a Community Hospital. Schumock GT, Stubbings J. How to Develop a Business Plan for Pharmacy Services. 3rd ed.. Lenexa, KS: American College of Clinical Pharmacy; 2018: 169 – 198

  • Gross AE, Xu H, Zhou D, Al-Huniti N. Simplified aztreonam dosing in patients with end stage renal disease: results of a Monte Carlo simulation.. Antimicrobial agents and chemotherapy. 2018;. doi:10.1128/AAC.01066-18.

  • Wang SK, Gilchrist A, Loukitcheva A, Plotkin BJ, Sigar IM, Gross AE, O’Donnell JN, Pettit N, Buros A, O’Driscoll T, Rhodes NJ, Bethel C, Segreti J, Charnot-Katsikas A, Singh K, Scheetz MH. Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.. Antimicrobial agents and chemotherapy. 2018;62(8). doi:10.1128/AAC.00382-18.

  • Spencer S, Ipema HJ, Hartke P, Krueger CD, Rodriguez R, Gross AE, Gabay MP. Intravenous Push Administration of Antibiotics: Literature and Considerations.. Hospital pharmacy. 2018;53(3):157-169. doi:10.1177/0018578718760257.

  • Stover KR, Kenney RM, King ST, Gross AE. Evaluation of the Use of Novel Biomarkers to Augment Antimicrobial Stewardship Program Activities.. Pharmacotherapy. 2018;38(2):271-283. doi:10.1002/phar.2069.

  • Gross AE, Johannes RS, Gupta V, Tabak YP, Srinivasan A, Bleasdale SC. The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 U.S. medical centers.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017;. doi:10.1093/cid/cix379.

  • Gross AE, Olsen KM, DiPiro JT, . Intra-abdominal infections. Joseph DiPiro, Robert L. Talbert, Gary Yee, Barbara Wells, L. Michael Posey. Pharmacotherapy: A Pathophysiologic Approach. New York, NY: McGraw-Hill; 2016: 1813-25

  • Means L, Bleasdale S, Sikka M, Gross AE. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.. Pharmacotherapy. 2016;. doi:10.1002/phar.1799.

  • Huang LL, Van Schooneveld TC, Huang RD, Olsen KM, Rupp ME, Gross AE. Guideline-Concordant Versus Discordant Antimicrobial Therapy in Patients With Community-Onset Complicated Intra-abdominal Infections.. Infection control and hospital epidemiology. 2016;:1-4. doi:10.1017/ice.2016.64.

  • Gross AE, Bryson ML. Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review.. The Annals of pharmacotherapy. 2015;. doi:10.1177/1060028015597449.

  • Olsen KM, Gross AE, DiPiro JT, . Intra-abdominal infections. Joseph DiPiro, Robert L. Talbert, Gary Yee, Barbara Wells, L. Michael Posey. Pharmacotherapy: A Pathophysiologic Approach. New York, NY: McGraw-Hill; 2014: 1821-34

  • Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, Kalil AC. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.. Antimicrobial agents and chemotherapy. 2014;58(9):5262-8. doi:10.1128/AAC.02582-14.

  • Commers T, Swindells S, Sayles H, Gross AE, Devetten M, Sandkovsky U. Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients.. The Journal of antimicrobial chemotherapy. 2014;69(1):262-7. doi:10.1093/jac/dkt323.

  • Wilde AM, Gross AE. A new practitioner’s guide to antimicrobial stewardship.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013;70(24):2180, 2182-3. doi:10.2146/ajhp130032.

  • Van Schooneveld TC, Gross AE, Kalil AC, . (2013). Comment on: Duodenal infusion of feces for recurrent Clostridium difficile. New England Journal of Medicine. Issue 22. Page(s) 2143.

  • Griffith MM, Patel JA, Sutton SH, Bolon MK, Esterly JS, Gross AE, Postelnick MJ, Zembower TR, Scheetz MH. Prospective approach to managing antimicrobial drug shortages.. Infection control and hospital epidemiology. 2012;33(7):745-52. doi:10.1086/666332.

  • Griffith MM, Gross AE, Sutton SH, Bolon MK, Esterly JS, Patel JA, Postelnick MJ, Zembower TR, Scheetz MH. The impact of anti-infective drug shortages on hospitals in the United States: trends and causes.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(5):684-91. doi:10.1093/cid/cir954.

    • Education

  • PGY2 Infectious Diseases Residency, Midwestern University, Chicago, IL

  • PGY1 Pharmacy Practice Residency, Henry Ford Hospital, Detroit, MI

  • PharmD, Purdue University, West Lafayette, IN

    • Licensures and Certifications

  • Board of Pharmacy Specialties, Board Certified Infectious Diseases Pharmacist (BCIDP), 2019

  • Board of Pharmacy Specialties, Added Qualifications in Infectious Diseases (AQ ID), 2016

  • Board of Pharmacy Specialties, Board Certified Pharmacotherapy Specialist (BCPS), 2012